Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer

NCT04192331 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: nab-paclitaxel regimen1
DRUG: nab-paclitaxel regimen2

Sponsor

Peking University Cancer Hospital & Institute